Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanism of Allogeneic Umbilical Cord Blood Therapy in Cerebral Palsy

NCT03130816 is registered in ClinicalTrials.gov with Bundang CHA Hospital as lead sponsor.

NCT NCT03130816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03130816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanism of Allogeneic Umbilical Cord Blood Therapy in Cerebral Palsy
Lead sponsor
Bundang CHA Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
July 29, 2015
Completion date
May 21, 2019
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy, child development